Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China
· Delayed Price · Currency is CNY 21.30
+0.75 (3.65%)
Mar 10, 2026, 3:04 PM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 2.36 billion as of March 10, 2026. Its market cap has increased by 21.03% in one year.
Market Cap
2.36B
Enterprise Value
3.63B
Revenue
626.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.30
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 2.36B, a decrease of -64.00%. That is a compound annual growth rate of -18.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 2.36B | 4.37% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Gdk Biological Technology | 2.31B |
| Guiyang Xintian Pharmaceutical | 2.43B |
| Zhejiang East Asia Pharmaceutical | 2.52B |
| Jiangsu CoWin Biotech | 2.53B |
| Hunan Nucien Pharmaceutical | 2.18B |
| Shanghai Serum Bio-Technology | 2.60B |
| Shandong Sito Bio-technology | 2.77B |
| Jilin Jian Yisheng Pharmaceutical | 2.78B |